SCHEMBL6238937

SCHEMBL6238937

C=[N+]c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3003406 0.69 ALDH1A1 (0.40)
Formaldehyde SCHEMBL27942429 0.65 CA4 (0.38)
SCHEMBL924562 0.64
SCHEMBL3008677 0.64
SCHEMBL691694 0.64
SCHEMBL7262793 0.64
SCHEMBL12892552 0.64
Ammonia Solution, Strong SCHEMBL23611461 0.62
Bromide SCHEMBL9014902 0.62
Hydrochloric Acid SCHEMBL1304764 0.62 CA4 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143371-A1 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors PHARMACIA CORPORATION (US) 2005-06-30 US claimed
US-20050137220-A1 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors PHARMACIA CORPORATION (US) 2005-06-23 US claimed
US-20050143371-A1 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors PHARMACIA CORPORATION (US) 2005-06-30 US disclosed
US-20050137220-A1 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors PHARMACIA CORPORATION (US) 2005-06-23 US disclosed
WO-2005009370-A2 BETA-CARBOLINE COMPOUNDS AND ANALOGUES THEREOF AND THEIR USE AS MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS PHARMACIA CORPORATION (US) 2005-02-03 WO disclosed
EP-0344707-A2 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives E.R. SQUIBB & SONS, INC. (US) 1989-12-06 EP disclosed
EP-0321928-A2 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines E.R. SQUIBB & SONS, INC. (US) 1989-06-28 EP disclosed